Bekaert et al.’s systematic review, encompassing 12 studies on resistin, indicated a significant association between elevated resistin levels and the occurrence or progression of NAFLD in half of the studies [24]. The gene discussed is RETN; the disease is metabolic dysfunction-associated steatotic liver disease.